Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-029256
Filing Date
2025-02-27
Accepted
2025-02-27 17:28:19
Documents
17
Effectiveness Date
2025-02-27

Document Format Files

Seq Description Document Type Size
1 S-8 xene-20250227.htm S-8 184194
2 EX-5.1 xene-ex5_1.htm EX-5.1 10772
3 EX-23.1 xene-ex23_1.htm EX-23.1 6247
4 EX-FILING FEES xene_exfilingfees.htm   iXBRL EX-FILING FEES 27897
5 GRAPHIC img3998686_0.jpg GRAPHIC 36649
6 GRAPHIC img3998686_1.jpg GRAPHIC 26886
  Complete submission text file 0000950170-25-029256.txt   450910

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT xene_exfilingfees_htm.xml XML 6933
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285382 | Film No.: 25681010
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)